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Abstract
Objective—This study aims to identify consumer-level predictors of level of treatment response 
to Illness Management and Recovery (IMR) in order to target the appropriate consumers and aid 
psychiatric rehabilitation settings in developing intervention adaptations.
Methods—Secondary analyses from a multi-site study of IMR were conducted. Self-report data 
from consumer participants of the parent study (n = 236) were analyzed for the current study. 
Consumers completed pre-post surveys assessing illness management, coping, goal-related hope, 
social support, medication adherence, and working alliance. Correlations and multiple regression 
analyses were run in order to identify self-report variables that predicted level of treatment 
response to IMR.
Results—Analyses revealed that goal-related hope significantly predicted level of improved 
illness self-management, (F (1, 164) = 10.93, p <.001, R2 = .248, R2 Change = .05). Additionally, 
we found that higher levels of maladaptive coping at baseline were predictive of higher levels of 
adaptive coping at follow-up, (F (2, 180) = 5.29, p < .02, R2 = .38, R2 Change = .02). Evidence did 
not support additional predictors.
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Conclusions and Implications for Practice—Previously, consumer-level predictors of level 
of treatment response have not been explored for IMR. Although two significant predictors were 
identified, study findings suggest more work is needed. Future research is needed to identify 
additional consumer-level factors predictive of IMR treatment response in order to identify who 
would benefit most from this treatment program.
Keywords
illness management and recovery; predictors; psychosocial intervention; severe mental illness; 
psychiatric rehabilitation
Understanding consumer factors that predict responsiveness to an intervention can facilitate 
targeting the intervention to the appropriate consumers as well as highlight ways in which 
the intervention may be modified in order to better treat neglected consumer populations. 
Indeed, consumer factors account for a substantial portion of variation in outcomes in 
psychotherapeutic interventions; in some cases, up to 40% of variations in outcomes are due 
to consumer factors (Beutler, Bongar, & Shurkin, 2000; Blow & Sprenkle, 2001; Duncan & 
Miller, 2000; Hamilton & Dobson, 2002; Tallman & Bohart, 1999). Reviews of the 
effectiveness of therapeutic interventions (Wampold, 2013) and self-management programs 
(Trappenburg et al., 2013) find that between-consumer variation within intervention types is 
much greater than differences between intervention types.
One area of consumer characteristics that consistently impacts treatment response is 
cognitive functioning (Heinssen, Liberman, & Kopelowicz, 2000; Mueser, Kosmidis, & 
Sayers, 1992; Silverstein, Menditto, & Stuve, 1999). Research suggests that cognitive 
processing difficulties can restrict individuals with severe mental illness (SMI)’s ability to 
learn and generalize new skills from psychosocial interventions (Corrigan, Wallace, Schade, 
& Green, 1995; Kern, Green, & Satz, 1992; Lysaker, Bell, Zito, & Bioty, 1995). Difficulties 
with sustained attention can impact group attendance, which in turn impacts treatment 
response (Kern et al., 1992; McKee, Hull, & Smith, 1997). Finally, verbal memory deficits 
have been shown to mediate skill learning in samples of individuals with schizophrenia 
(Silverstein, Schenkel, Valone, & Nuernberger, 1998; Smith, Hull, Romanelli, Fertuck, & 
Weiss, 1999). These findings suggest the degree of cognitive impairment may play an 
important role in responsiveness to treatment by impacting one’s ability to learn and 
generalize the skills from an intervention.
Outside of cognitive functioning, consumer factors that impact treatment response have been 
found to vary based on the population and the targets of the intervention. For example, in 
medical studies focusing on illness self-management of diabetes, asthma, and epilepsy, 
consumer social support has been shown to be positively related to greater illness self-
management at the end of treatment (Gallant, 2003; Rosland et al., 2008). Improved illness 
self-management outcomes have also been linked to higher patient activation and 
engagement (Hibbard & Greene, 2013; Hibbard, Mahoney, Stock, & Tusler, 2007; Kukla, 
Salyers, & Lysaker, 2013) and perceived quality of the patient-physician relationship 
(Heisler, Bouknight, Hayward, Smith, & Kerr, 2002). Lower levels of perceived hope and 
reduced use of active and adaptive coping strategies have been found to be predictive of 
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poorer treatment outcomes in consumers with schizophrenia (Hoffmann, Kupper, & Kunz, 
2000). Explorations of positive treatment response in certain psychosocial interventions, 
such as cognitive-behavior therapy for schizophrenia and self-help groups, have found that 
demographic variables such as being female, having a diagnosis of schizophrenia, greater 
flexibility of delusional content, and higher education level act as predictors to treatment 
outcomes (Brabban, Tai, & Turkington, 2009; Garety et al., 1997; Powell, Yeaton, Hill, & 
Silk, 2001). Taken together, it is evident that the clinical and demographic consumer 
characteristics affecting treatment responsiveness appear to largely vary between different 
psychosocial interventions (Heinssen et al., 2000; Schaub, Behrendt, Brenner, Mueser, & 
Liberman, 1998).Thus, the primary aim of this study was to identify the specific consumer 
factors that impact treatment responsiveness for Illness Management and Recovery (IMR).
IMR is an evidence-based practice shown to be effective at teaching participants with SMI 
knowledge and skills for managing their disorder (Mueser et al., 2002; Mueser et al., 2006). 
IMR uses psychoeducation, motivational interviewing, and cognitive-behavioral strategies to 
improve self-management of mental illnesses by teaching participants how to set and 
achieve goals related to their personal recovery (Mueser et al., 2006; Salyers, Godfrey, 
Mueser, & Labriola, 2007). In addition to goal setting, IMR provides education about 
disorders, relapse prevention training, and establishes personalized coping skills to help 
participants manage persistent symptoms (McGuire et al., 2014; Salyers et al., 2009). The 
effectiveness of IMR at improving illness self-management and coping skills has been 
supported by four randomized controlled trials and numerous pre-post trials (RCTs; Färdig, 
Lewander, Melin, Folke, & Fredriksson, 2011; Hasson-Ohayon, Roe, & Kravetz, 2007; 
Levitt et al., 2009; Mueser et al., 2006; Salyers et al., 2009; Salyers et al., 2014; Salyers et 
al., 2010; Salyers, Rollins, Clendenning, McGuire, & Kim, 2011).
Despite robust evidence for overall treatment effects, consumers receiving IMR vary 
substantially in their responsiveness (McGuire et al., 2014). Moreover, in our recently 
completed multi-site trial (see Methods section for description), only 38% of consumers 
with SMI demonstrated a substantial increase in illness self-management (McGuire et al., 
2016). Looking across other RCT studies of IMR, both sample characteristics and treatment 
effect sizes for the IMR condition have varied substantially. For instance, samples differed in 
diagnoses (80% vs 13% with a schizophrenia diagnosis; Hasson-Ohayon et al., 2007; Levitt 
et al., 2009), mean age (52.91 vs 33.92; Hasson-Ohayon et al., 2007; Levitt et al., 2009), and 
race (predominantly black samples vs. predominantly white samples; Levitt et al., 2007; 
Salyers et al., 2014;). These diverse settings and samples were associated with substantial 
variation in pre-post intervention improvement on illness self-management, ranging from 
0.00 (Salyers et al., 2014) to 0.38 (Hasson-Ohayon et al., 2007).
Given the substantial variability in treatment responsiveness across samples and between 
consumers within the same sample who receive IMR, and the impact this variability can 
have on effectiveness of psychiatric rehabilitation services, the current study aims to 
examine the role of consumer factors in predicting higher levels of illness self-management 
upon completion of IMR. A primary focus of IMR is improving illness self-management as 
a means to support recovery (Hasson-Ohayon et al., 2007). Because higher levels of 
perceived social support (Gallant, 2003; Rosland et al., 2008), hope (Hoffmann et al., 2000), 
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and coping strategies (Hoffmann et al., 2000) have been tied to improved recovery and 
illness self-management in other intervention approaches, we hypothesized that higher levels 
of perceived social support, hope, and coping at baseline would predict higher levels of 
illness self-management at the end of treatment (Hypothesis 1).
In addition to illness self-management, IMR aims to develop personalized adaptive coping 
skills for consumers to aid in recovery (McGuire et al., 2014; Salyers et al., 2009). Within 
chronically ill and SMI samples, research has demonstrated a positive relationship between 
perceived social support and the development of coping strategies (Luszczynska, Mohamed, 
& Schwarzer, 2005; Macdonald, Pica, McDonald, Hayes, & Baglioni Jr, 1998). Further, 
empirical work (Ashton et al., 2005) and theoretical models suggest that social support is a 
predictor of greater prospective coping (Schwarzer & Knoll, 2007; Valentiner, Holahan, & 
Moos, 1994). We therefore hypothesize that higher levels of perceived social support at 
baseline (i.e., prior to IMR), and lower levels of maladaptive coping will predict higher 
levels of response to IMR as indicated by higher levels of adaptive coping (Hypothesis 2). 
As this is the first examination of consumer factors affecting treatment response to IMR, we 
also included exploratory analyses of additional consumer-level factors (e.g. medication 
adherence, working alliance, demographics) in order to inform areas of future study.
Methods
Setting and Sample
The current study is a secondary analysis of data collected for a larger, multi-site trial of 
IMR and has been described previously (McGuire et al., 2015). Briefly, participating sites, 
located in three states, provided IMR as part of routine practice. A total of 236 consumers 
participated in the study. The majority of consumers were non-Hispanic (75%) males (59%). 
Consumers average age was 45.2 (SD = 12.1) years old. Most participants identified as 
Caucasian (55%); with 32% of participants identifying as African American, 12% as other 
(1% as Native American or Pacific Islander, 2% as American Indian or Alaska native, 7% as 
more than one race, and 2% as unknown) and 1% as Asian. Most were not in school (93%) 
and their highest level of education was high school (65%). The vast majority were not 
employed (83%) or married (93%). Self-reported diagnoses were not mutually exclusive (i.e. 
some consumers provided multiple responses) and included: psychotic disorders (44%), 
depression (34%), bipolar disorder (24%), posttraumatic stress disorder (PTSD; 11%), other 
anxiety disorders (5%), and other diagnoses (4%). A small percentage of consumers 
reported no diagnosis (8%).
Procedures
The study team assigned each IMR provider three to four randomly selected IMR modules 
to complete, prior to completing the remainder of the IMR program. This was done to ensure 
all modules were covered within the study time period. While IMR does not have to be 
provided sequentially, including randomly assigned modules ensured the study team would 
obtain samples from all modules across the study. All providers were asked to conduct IMR 
according to the manual. Prior to the first IMR session, study team personnel met with 
potential consumers in person to obtain informed consent and administer baseline measures. 
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Consumers who were unable to attend this meeting were eligible for a telephone consent and 
baseline process. The study team obtained a waiver of written informed consent from the 
Institutional Review Board for these participants. Potential participants received a hard copy 
of all baseline measures from their IMR group leader prior to the telephone call. Study 
personnel reviewed the consent materials and answered any questions before asking the 
participant to verbally agree to participate. Consumers completed the baseline masures over 
the phone with the study team member. Follow-up surveys were completed in person and 
administered three months after their study start date. Consumers were given a gift-card for 
completing the study surveys. For additional study details see McGuire et al. (2015).
Measures
Primary outcome measures
Illness self-management: The 15-item Illness Management and Recovery Scale (IMRS) 
(Mueser et al., 2004) is designed to evaluate illness self-management outcomes based on the 
stress-vulnerability model (Liberman et al., 1986; Zubin & Spring, 1977). The IMRS was 
selected as a widely used measure of recovery tailored specifically to the treatment targets of 
the IMR program (McGuire, Kean, Bonfils, Presnell, & Salyers, 2014; Scheyett, DeLuca, & 
Morgan, 2013). Illness self-management is a key outcome of the IMR intervention and 
accordingly, was used to assess level of treatment response. Each item is rated on a 5-point 
behaviorally anchored scale. Previous studies have found adequate internal consistency, test-
retest reliability, and convergent validity for the measure in SMI samples (Färdig, Lewander, 
Fredriksson, & Melin, 2011). Similarly, internal consistency was good in the current sample 
(α = 0.79).
Coping skills: Brief COPE is 28-item scale designed to measure an individual’s coping 
style. Coping strategies are a primary target of IMR and therefore are an indicator of 
treatment response. Items are rated using a 4-point likert scale ranging from 1 (I haven’t 
been doing this) to 4 (I’ve been doing this a lot) for each indicated coping strategy. The Brief 
COPE is comprised of two subscales: adaptive and maladaptive coping strategies 
(SAMHSA, 2012). The adaptive coping subscale measures whether individuals utilize 
emotional support or planning skills to cope with problems that may arise. The maladaptive 
subscale measures whether an individual engages in self-blame or denial behaviors. Good 
reliability and internal consistency have been demonstrated with SMI populations (Drake et 
al., 1998; SAMHSA, 2012). In our sample, the internal consistency was good for the 
adaptive coping subscale (α = 0.84) but was lower for the maladaptive subscale (α = 0.66). 
This measure was selected for its ability to detect fine-grain improvements in coping 
strategies, which appear to have a unique association with the overall ability of people to 
cope with serious mental illness (Meyer, 2001).
Predictor Measures—All predictor measures were self-report measures collected at 
baseline along with the participants’ consent. A member of the research team was available 
throughout the completion of the measures to respond to any questions participants’ had in 
filling out the self-report items.
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Demographics: Consumers were asked to report on age, sex, race, ethnicity, birth date, 
diagnosis, education background, marital status, employment status, their living 
arrangements, and if they participated in volunteer activities. Additionally, participants were 
asked if they had ever participated in IMR before.
Beliefs about IMR: Consumers were asked to answer three questions related the beliefs 
about their participation in IMR. The questions asked whether consumers believed coming 
to IMR would be helpful, whether participation in IMR was important to their recovery and 
whether their believed their attendance to IMR would be consistent. Each question was rated 
by the consumer on a 5-point scale ranging from 1 (Strongly Disagree) to 5 (Strongly 
Agree).
Medication adherence: The Medication Adherence Rating Scale (MARS) is a 10 item self-
report measure developed to measure an individual’s adherence to their prescribed 
medication regimen (Thompson, Kulkarni, & Sergejew, 2000). Each item is rated 
dichotomously with 1 “yes” and 0 “no.” The scale has been found to have moderate internal 
consistency (α = 0.60) (Hackman et al., 2007; Thompson et al., 2000). In our sample 
internal consistency was acceptable (α = .75)
Goal-related hope: The Adult State Hope Scale (Snyder et al., 1996) is a six item measure 
containing two subscales: pathways (“I energetically pursue my goals”) and agency (“There 
are lots of ways around any problem”) (Snyder et al., 1996). Each subscale contains three 
questions that are rated on a 4-point scale ranging from 1 (Definitely False) to 4 (Definitely 
True). The scale has previously shown to have good internal consistency, high levels of 
convergent and discriminant validity, and sensitivity (Snyder et al., 1996). The measure was 
found to be appropriate for SMI populations (McGrew, Johannesen, Griss, Born, & Vogler, 
2004). Good internal consistency was found for our sample (α = 0.85).
Social support: The Multidimensional Scale of Perceived Social Support (MSPSS) is a 12 
item measure used to assess one’s current level of perceived social support. Respondents 
indicate the degree to which they agree with each statement on a 7-point likert scale ranging 
from 1 (“Very Strongly Disagree”) to 7 (“Very Strongly Agree”). The MSPSS has previously 
demonstrated high test-retest reliability and internal consistency in a schizophrenia sample 
(Zimet, Dahlem, Zimet, & Farley, 1988). The scale was found to be appropriate and reliable 
in a sample of persons diagnosed with schizophrenia (Cecil, Stanley, Carrion, & Swann, 
1995). Internal consistency for this sample was excellent (α = 0.95).
Working alliance: The Working Alliance Inventory Short Form (WAI-S) Client Version is a 
12 item measure used to assess the working alliance between the clinician and consumer. 
Each item is rated on a 7-point likert scale ranging from 1 (“Very Strongly Disagree”) to 7 
(“Very Strongly Agree”). This measure has been found to be appropriate for SMI 
populations (Busseri & Tyler, 2003; Gehrs & Goering, 1994; Horvath & Greenberg, 1989; 
Tracey & Kokotovic, 1989) and to have good reliability and validity (Horvath & Greenberg, 
1989; Tracey & Kokotovic, 1989). Internal consistency was good within our sample (α = 
0.84).
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Statistical Analyses
To test our hypotheses and exploratory analyses, we performed a series of analyses to 
determine if self-reported variables were associated with higher levels of response to IMR. 
Treatment response was measured using three-month follow-up scores from the IMRS and 
the Adaptive Coping Subscale of the Brief COPE. Due to well-known statistical and 
conceptual problems associated with binary responder analyses (Snapinn & Jiang, 2007; 
Uryniak et al., 2011), all analyses in this study used untransformed continuous scores rather 
than artificially dichotomized variables.
First, as individual consumer data for this sample was nested within clinicians’ IMR groups, 
an intercepts only model was run. The model parameter estimate was not significant, 
indicating that significant differences in participants’ response to treatment were not 
accounted for at the clinician level. Treatment responses across individual participants did 
not vary based on the clinician providing the IMR intervention. With these results in mind, 
the researchers opted to not run analyses as multilevel models. Additionally, correlations and 
regressions were analyzed using the change scores for each treatment outcome measure, as 
well as the follow-up scores for these measures. We have opted to report on the residual 
follow-up scores, while controlling for baseline scores for each of the treatment outcomes, 
as change scores do not take into account imbalanced baseline samples, which our data had 
(Allison, 1990; Vickers & Altman, 2001) Additionally, with our data, due to varying levels 
of baseline scores from participants, utilizing change scores as the dependent variable results 
in regression to the mean (Bland & Altman, 1994a, 1994b; Vickers & Altman, 2001).
The following procedure was used to determine baseline factors associated with higher 
levels of treatment response. All analyses were conducted as to reduce Type I error, given 
the large number of self-report variables being assessed. First, to test our hypothesis that 
higher levels of perceived social support, hope, and coping at baseline would predict higher 
levels of illness self-management and to explore additional baseline self-report variables that 
may act as predictors to treatment response as defined by higher scores on the IMRS, 
Pearson bivariate correlations were conducted between IMRS follow-up scores and baseline 
self-report variables. Self-report variables significantly associated (p < .05) with the IMRS 
follow-up scores, including those hypothesized as significant predictors, were then entered 
together into a multiple regression model in which IMRS follow-up scores were entered as 
the dependent variable and baseline scores for the IMRS were entered as a covariate to 
control for baseline levels of illness self-management. Multiple regression analyses were 
performed, and only variables significantly adding to the model (p < .05) were retained. To 
test our hypothesis that higher levels of perceived social support at baseline and lower levels 
of maladaptive coping would predict higher treatment response to IMR as defined by higher 
follow-up scores for adaptive coping and to explore baseline self-report variables that may 
act as additional predictors to treatment response as defined by higher scores on the 
Adaptive Coping Subscale, the same procedure was repeated using the BC Adaptive Coping 
Subscale as the dependent variable.
As predictor variables had the potential to be correlated with one another, multicollinearity 
was assessed for each of regression model. Correlation matrices of the self-report variables 
were examined, , and variables that were moderately or highly correlated were identified. 
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These variables were further examined upon inclusion in the regression models. Within the 
regression models, when all self-report variables significantly correlated with the dependent 
variable were added, the Variance Inflation Factor (VIF) was examined for each independent 
variable to determine the likelihood of multicollinearity (Dormann et al., 2013; Stine, 1995). 
As lower VIF scores indicate less likelihood of multicollinearity problems (Alin, 2010), any 
variable that received a VIF score greater than five (the common threshold for detecting 
multicollinearity) was removed from the regression model as it was likely correlating so 
highly with other independent variables that it was undermining statistical significance of 
the model (Craney & Surles, 2002; Dormann et al., 2013; Stine, 1995).
Results
Correlations
Significant Pearson bivariate correlations between baseline self-report variables and follow-
up scores for both IMRS and Brief COPE Adaptive Coping Subscale can be found in Table 
1. The correlations between the baseline self-report variables can be found in Table 2. Of the 
variables tested, 11 significantly correlated with the IMRS follow-up scores, including the 
hypothesized hope subscales (Goal State Hope Pathways Subscale r = .36, p <.001; Goal 
State Hope Agency Subscale r = .40, p <.001), adaptive coping (Brief COPE Adaptive 
Subscale r = .37, p <.001) and perceived social support (MSPSS r = .34, p <.001). In terms 
of our second hypothesis, there were 12 variables that significantly correlated with Brief 
COPE Adaptive Coping Subscale follow-up scores, including perceived social support 
(MSPSS r = .21, p <.05) and maladaptive coping (Brief COPE Maladaptive Subscale r = .61, 
p <.001). No demographic variables, and no variables related to Working Alliance (WAI-S) 
were significantly correlated with either outcome measure and thus were not included in 
multiple regressions. The 11 variables that significantly correlated with IMRS follow-up 
scores and the 12 variables that significantly correlated with Brief COPE Adaptive Subscale 
follow-up scores were then entered into a multiple regression predicting either IMRS follow-
up scores or Brief COPE Adaptive Subscale follow-up scores respectively.
Multicollinearity Analyses
The correlation matrix of predictor variables (see Table 2) was examined for extremely high 
correlations between independent variables. Most variables had a low to moderate 
correlation with one another, except for Goal Scale Total Score, which was highly correlated 
with both Goal Scale subscales (Goal Scale Pathways Subscale r = .90, p<.001; Goal Scale 
Agency Subscale r = .92, p<.001). Because highly correlated variables may undermine the 
independent variables within a regression model (Alin, 2010; Lin, 2008; Stine, 1995), both 
subscales were excluded, and only the Goal Scale Total Score was used in future analyses.
The initial regression models for both dependent variables included all the remaining 
predictor variables that has significantly correlated with each dependent variable. The 
tolerance and VIF statistics were examined within these first models to determine whether 
multicollinearity was problematic. As Table 3 and Table 4 illustrate, no predictor variable 
had a VIF score reaching five or greater, thus we determined multicollinearity to not be a 
concern in either model.
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Predictors of Treatment Response (Hypotheses 1 and 2)
Our first hypothesis that higher levels of perceived social support, hope, and adaptive coping 
at baseline would predict higher levels of illness self-management at follow-up was only 
partially supported. After controlling for baseline illness self-management (IMRS), only 
hope (Goal Scale Total Score) explained a significant amount of variance in the IMRS scores 
at follow-up, (F (1, 179) = 11.52, p <.001, R2 = .26, R2 Change = .05; See Table 5), while 
neither perceived social support (MSPSS) nor adaptive coping (Brief COPE Adaptive 
Subscale) significantly predicted illness self-management at follow-up.
Our second hypothesis that higher levels of perceived social support and lower levels of 
maladaptive coping (Brief COPE Maladaptive Subscale) at baseline would be associated 
with increases in adaptive coping at follow-up was not supported. In fact, analyses suggested 
that after controlling for baseline adaptive coping, higher levels of maladaptive coping at 
baseline predicted higher levels of adaptive coping at follow-up, (F (2, 180) = 5.29, p < .02, 
R2 = .38, R2 Change = .02; See Table 6).
Exploratory Analyses
Follow-up scores on the IMRS significantly correlated with 8 baseline variables in addition 
to the three hypothesized variables, and follow-up scores on the Brief COPE Adaptive 
Coping subscale significantly correlated with 10 baseline variables in addition to the two 
hypothesized variables (see Table 1 for all significant correlations); these variables were 
entered, along with the hypothesized predictors, into the multiple regression predicting 
IMRS follow-up scores or Brief Cope Adaptive subscale follow-up scores, respectively. 
However, none of these variables significantly predicted either IMRS or Brief COPE 
Adaptive subscale at follow-up after controlling for baseline levels of the IMRS and Brief 
COPE
Discussion
Improved understanding of consumer factors that predict level of treatment response can 
help to identify consumers who may receive the most benefit from a specific treatment, 
inform ways to adapt treatments, and highlight individuals who may need increased support 
to be successful with an intervention. Therefore, the study attempted to understand 
consumer-level factors that predict level of treatment response to IMR.
Engagement in Recovery and Response to IMR
Although study hypotheses were partially supported, a revised picture of the importance of 
specific baseline variables emerged from the results. Study results point to the role of 
individuals’ levels of hope and engagement in illness self-management and recovery. Two 
results highlight this role. First, as hypothesized, increased hope at baseline predicted 
increased treatment response as defined by improved illness self-management at follow-up. 
This finding is consistent with theories of recovery and previous empirical findings. Indeed, 
hope is often described as a major turning point for recovery within severe mental illness 
(Deegan, 1988; Lovejoy, 1984) and is a positive quality of life factor for individuals in this 
population (Kylmä, Juvakka, Nikkonen, Korhonen, & Isohanni, 2006). Second, empirical 
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studies have revealed that hope is predictive of improved outcomes in medical rehabilitation 
(Kortte, Stevenson, Hosey, Castillo, & Wegener, 2012) and is linked to better functional 
outcomes for individuals with schizophrenia (Hoffmann & Kupper, 2002; Hoffmann et al., 
2000; Hoffmann, Kupper, Zbinden, & Hirsbrunner, 2003; Lysaker, Campbell, & Johannesen, 
2005; Regenold, Sherman, & Fenzel, 1999). Second, higher levels of maladaptive coping 
successfully predicted improved adaptive coping at follow-up. IMR may allow for the re-
direction or teaching of new ways to channel coping strategies, allowing individuals who 
were coping in maladaptive ways at baseline to cope more adaptively as they progress 
through the intervention. It is easier to capitalize on motivation to use any coping skills than 
to overcome hopelessness, apathy, lack of motivation or an unwillingness to cope.
Taken together, hope and maladaptive coping both represent openness to and continued 
attempts at self-management of illness. Conceptually, hope may be necessary for individuals 
to summon the motivation and sufficiently engage personal resources to benefit from self-
management interventions such as IMR. Maladaptive coping may be tied to overall attempts 
to cope (Zeidner & Saklofske, 1996), thus, those who engage in maladaptive coping may 
benefit more from IMR, as they have identified that a problem exists and may not be aware 
of more adaptive ways to cope with the problem. Although not measured in the current 
study, hope and maladaptive coping may tap into core motivational factors (e.g., individuals’ 
self-efficacy, autonomy, and expectancy) which may be necessary to meaningfully engage in 
an active self-management intervention. Therefore, identifying individuals who have higher 
levels of hope and pathways to managing their illness may allow for more successful IMR. 
In contrast, individuals with lower levels of hope may require additional supports, such as 
peer services which have shown to increase hope, prior to engaging in self-management 
programs such as IMR (Davidson, Bellamy, Guy, & Miller, 2012; Sledge et al., 2011). 
Similarly, those who have higher levels of maladaptive coping skills prior to treatment may 
also be good candidates for IMR.
Adaptive coping at baseline and perceived social support at baseline were hypothesized to 
predict level of treatment response, yet no significant relationship was found to illness self-
management at follow-up. It is possible that individuals with high levels of adaptive coping 
at the start of IMR, are already utilizing many of the strategies taught within the 
intervention. If this is the case, these individuals may not benefit as much from the IMR 
material covered. An alternative explanation may be that increasing adaptive coping skills 
and social support are both targets of IMR, thus baseline levels of these consumer factors are 
irrelevant, as the program itself creates an environment in which these l factors can grow. 
Although both of these variables have been shown to be predictive of level of treatment 
response for other interventions (Gallant, 2003; Hoffmann et al., 2000; Rosland et al., 2008), 
it appears they may not be requisites for success in IMR. This may further expand the range 
of individuals IMR is appropriate for.
Study Limitations
Results should be considered with a few limitations in mind. No measures of symptoms 
were available for inclusion in these analyses. Given that negative symptoms may impact 
treatment engagement (Saperstein & Medalia, 2015) and the development and utilization of 
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social support and coping strategies, future studies should also seek to examine whether 
these symptoms also impact IMR treatment response. Diagnoses, which have been a 
predictive factor in other interventions, were self-reported in our study and multiple 
diagnoses could be provided, making it difficult to determine primary diagnoses and 
potentially resulting in imprecise reporting of the variable. Finally, the intervention period 
itself was brief, as participants only received three months of IMR. While treatment response 
was detected, it is possible that a longer duration of intervention would have allowed for a 
greater degree of treatment response, increasing the ability to detect significant relationships.
Implications for Psychiatric Rehabilitation
Results from the current study point towards a potential staged referral and intervention 
process within psychiatric rehabilitation settings that would include distinguishing 
consumers who would most benefit from immediate participation in IMR from those who 
may need additional support. Findings from the current study indicate those who are more 
hopeful upon starting IMR, or those who have any coping skills, including maladaptive ones, 
may see better results with IMR. Thus, a staged referral process could be implemented using 
consumer’s baseline levels of hope, or existing coping skills, to identify those individuals 
ready to begin IMR. Potential IMR participants could be pre-screened with a short baseline 
assessment to gather information on these characteristics. Individuals with higher levels of 
hope or those utilizing a greater number of coping skills could advance directly to IMR, 
while those who screened lower for these variables, could receive targeted interventions that 
increase these characteristics prior to starting IMR (e.g. motivational interviewing to 
increase treatment engagement, peer support to increase hope, preliminary development of 
coping skills). Such a process could benefit consumers by reducing time spent in ineffective 
programming and better personalizing services to their individual needs. Meanwhile the 
process could benefit psychiatric rehabilitation settings by maximizing the percentage of 
IMR recipients who benefit from the intervention, reducing staff inefficiencies and reducing 
costly program dropouts.
Future Directions and Conclusions
The current study highlights the need for additional work to establish what makes level of 
response to IMR different across individuals. Self-report variables from this study were 
largely unsuccessful at explaining the variance in treatment response. While the current 
work provides a starting point for individuals who may be best served through IMR, it is not 
yet clear who else may benefit from this intervention. Future research identifying additional 
consumer-level variables that predict level of response to IMR is needed. Utilizing both self-
report and observer-rated measures may allow for stronger predictors to be identified. 
Identifying these consumer factors will aid psychiatric rehabilitation settings in tailoring 
IMR interventions, creating more precise referral processes, and better allocating valuable 
resources.
In conclusion, although substantial variability is observed in outcomes between consumers 
receiving IMR services, self-reported consumer factors assessed at baseline were largely 
unsuccessful in predicting responsiveness. Hope at baseline does emerge as predictive and 
should be the focus of additional pre-IMR assessment and support (e.g., peer services). 
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Future research should focus on theoretically-derived factors like motivation that may affect 
responsiveness s, as well as factors outside of the consumer which may affect responsiveness 
such as clinician factors or treatment environment.
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Table 1
Means, Standard Deviations and Correlations for Variables at Baseline
Outcome Measures at Follow Up
Self-Report Variables at Baseline M (SD) IMRS Adaptive Coping
Belief IMR Will Be Helpful 3.97 (1.16) 0.28** 0.36**
Belief Coming to IMR Is Important 4.12 (1.13) 0.22** 0.37**
Belief IMR Attendance Will Be Consistent 4.27 (1.12) 0.17* 0.32**
IMRS 3.55 (.64) 0.46** 0.32**
MARS 2.45 (1.86)
−0.21** −0.18*
Goal Scale Agency Subscale 9.20 (2.30) 0.36** 0.15*
Goal Scale Pathways Subscale 9.21 (2.06) 0.4** 0.15*
Goal Scale Total Score 18.41 (3.96) 0.42** 0.17*
MSPSS 4.94 (1.67) 0.34** 0.21*
WAI 5.65 (.99) 0.27** 0.3**
Adaptive Coping 5.64 (1.35) 0.37** 0.61**
Maladaptive Coping 4.46 (1.17) −
.448**
Notes: M= Mean, SD = Standard Deviation, IMR = Illness Management and Recovery, the intervention being studied; IMRS = Illness Management 
and Recovery Scale; MARS = Medication Adherence Rating Scale; MSPSS = Multidimensional Scale of Perceived Social Support; WAI = 
Working Alliance Inventory.
*
= p<.05;
**
= p<.001
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Table 3
Multicollinearity Statistics for Initial Multiple Regression Model for Illness Management and Recovery Scale 
at Follow-Up
Predictor Tolerance VIF
Belief IMR Will Be Helpful .31 3.27
Belief Coming to IMR Is Important .24 4.20
Belief IMR Attendance Will Be Consistent .41 2.41
IMRS .48 2.10
MARS .84 1.21
Goal Scale Total Score .58 1.71
MSPSS .59 1.71
WAI .77 1.30
Adaptive Coping .58 1.73
Notes: IMRS = Illness Management and Recovery Scale; MARS = Medication Adherence Rating Scale; MSPSS = Multidimensional Scale of 
Perceived Social Support; WAI = Working Alliance Inventory.
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Table 4
Multicollinearity Statistics for Initial Multiple Regression Model for Adaptive Coping Subscale at Follow-Up
Predictor Tolerance VIF
Belief IMR Will Be Helpful .31 3.27
Belief Coming to IMR Is Important .23 4.27
Belief IMR Attendance Will Be Consistent .41 2.41
IMRS .48 2.10
MARS .78 1.29
Goal Scale Total Score .57 1.80
MSPSS .58 1.71
WAI .77 1.30
Adaptive Coping .41 2.43
Maladaptive Coping .56 1.74
Notes: IMRS = Illness Management and Recovery Scale; MARS = Medication Adherence Rating Scale; MSPSS = Multidimensional Scale of 
Perceived Social Support; WAI = Working Alliance Inventory.
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